Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.
The Effect of Percussion Therapy on Neck Functional Disability, Pain and Upper Trapezius Muscle Properties Assessed by Elastography and Doppler Ultrasound in Patients With Neck Pain.
1 other identifier
interventional
35
1 country
1
Brief Summary
This study evaluates whether a single session of percussion therapy can reduce muscle tension and increase blood flow in the transverse cervical artery in individuals with neck pain. The investigators will evaluate muscle stiffness using ultrasound elastography, and assess blood flow in the transverse cervical artery via Doppler imaging before and after treatment. The primary objective is to determine how this therapy affects neck muscle relaxation and vascular responses, specifically within the upper trapezius region.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
June 17, 2026
June 1, 2026
2 years
June 1, 2026
June 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neck pain intensity on Visual Analog Scale (VAS)
Neck pain intensity evaluated using a Visual Analog Scale slide scale (score range 0-10, where 0 = no pain and 10 = worst imaginable pain). The patient marks their pain level using the slider, and the result is recorded as a numerical score. Unit of Measure: points
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Secondary Outcomes (11)
Neck pain-related disability on Neck Disability Index (NDI)
Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)
Shear-wave elastography of upper trapezius muscle: mean stiffness
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: oscillation frequency
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: dynamic stiffness
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: decrement
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
- +6 more secondary outcomes
Other Outcomes (3)
Peak systolic velocity (Vs) of the transverse cervical artery.
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
End-diastolic velocity (Vd) of the transverse cervical artery.
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Resistive index (RI) of the transverse cervical artery.
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Study Arms (2)
Percussion Therapy Arm
EXPERIMENTALSubjects receiving percussion therapy using a massage device. Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.
Longitudinal Stripping Massage Arm
EXPERIMENTALSubjects receiving manual longitudinal stripping massage. Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.
Interventions
Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.
Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.
Eligibility Criteria
You may qualify if:
- Age: 18-60 years
- Neck pain persisting for at least 3 months
- Visual Analog Scale (VAS) score between 3 and 7
- Neck Disability Index (NDI) between 30% and 48%
You may not qualify if:
- Pregnancy and postpartum period
- History of cervical spine or shoulder surgery
- Diagnosed fibromyalgia, radiculopathy, or myelopathy
- Myofascial therapy within the last 3 months
- Use of analgesic medication within 48 hours before assessment
- Venous diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poznań University of Physical Education
Poznan, 61-871, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The ultrasonographer performing elastography and Doppler assessments will be blinded to participants' treatment allocation
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Associate Professor
Study Record Dates
First Submitted
June 1, 2026
First Posted
June 5, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2029
Last Updated
June 17, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect patient privacy and confidentiality in accordance with GDPR regulations and local bioethics committee guidelines.